VITASPRING BIOMEDICAL CO., LTD. (VSBC) Gross margin 2018–2022
VITASPRING BIOMEDICAL CO., LTD. (VSBC) gross margin by fiscal year — reported gross profit divided by reported revenue.
36.8%FY2022 · since FY2018: 69.9% → 36.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 36.8% | -8.4 pp |
| FY2021 | 45.2% | +34.0 pp |
| FY2020 | 11.2% | -68.7 pp |
| FY2019 | 79.8% | +10.0 pp |
| FY2018 | 69.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice